vs
Side-by-side financial comparison of ASGN Inc (ASGN) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $970.0M, roughly 1.4× ASGN Inc). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs 0.6%, a 0.9% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs -3.0%). ASGN Inc produced more free cash flow last quarter ($9.1M vs $5.2M). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -3.2%).
ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
ASGN vs SEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $970.0M | $1.4B |
| Net Profit | $5.5M | $20.2M |
| Gross Margin | 27.5% | — |
| Operating Margin | 2.9% | 4.6% |
| Net Margin | 0.6% | 1.4% |
| Revenue YoY | -3.0% | 6.4% |
| Net Profit YoY | -73.7% | 225.7% |
| EPS (diluted) | $0.13 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $970.0M | — | ||
| Q4 25 | $980.1M | $1.4B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $968.3M | $1.4B | ||
| Q4 24 | $985.0M | $1.3B | ||
| Q3 24 | $1.0B | $1.3B | ||
| Q2 24 | $1.0B | $1.3B |
| Q1 26 | $5.5M | — | ||
| Q4 25 | $25.2M | $20.2M | ||
| Q3 25 | $38.1M | $28.8M | ||
| Q2 25 | $29.3M | $40.6M | ||
| Q1 25 | $20.9M | $56.7M | ||
| Q4 24 | $42.4M | $-16.1M | ||
| Q3 24 | $47.5M | $55.6M | ||
| Q2 24 | $47.2M | $77.6M |
| Q1 26 | 27.5% | — | ||
| Q4 25 | 28.9% | — | ||
| Q3 25 | 29.4% | — | ||
| Q2 25 | 28.7% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 29.0% | — | ||
| Q3 24 | 29.1% | — | ||
| Q2 24 | 29.1% | — |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 5.7% | 4.6% | ||
| Q3 25 | 6.7% | 5.4% | ||
| Q2 25 | 5.8% | 6.5% | ||
| Q1 25 | 4.8% | 8.3% | ||
| Q4 24 | 7.5% | 1.6% | ||
| Q3 24 | 7.7% | 4.3% | ||
| Q2 24 | 7.8% | 5.8% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 2.6% | 1.4% | ||
| Q3 25 | 3.8% | 2.1% | ||
| Q2 25 | 2.9% | 3.0% | ||
| Q1 25 | 2.2% | 4.2% | ||
| Q4 24 | 4.3% | -1.2% | ||
| Q3 24 | 4.6% | 4.4% | ||
| Q2 24 | 4.6% | 6.1% |
| Q1 26 | $0.13 | — | ||
| Q4 25 | $0.58 | $0.17 | ||
| Q3 25 | $0.87 | $0.23 | ||
| Q2 25 | $0.67 | $0.32 | ||
| Q1 25 | $0.48 | $0.44 | ||
| Q4 24 | $0.94 | $-0.12 | ||
| Q3 24 | $1.06 | $0.43 | ||
| Q2 24 | $1.02 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $143.6M | $26.5M |
| Total DebtLower is stronger | $1.5B | $1.8B |
| Stockholders' EquityBook value | $1.8B | $1.7B |
| Total Assets | $4.0B | $5.9B |
| Debt / EquityLower = less leverage | 0.82× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $143.6M | — | ||
| Q4 25 | $161.2M | $26.5M | ||
| Q3 25 | — | $60.1M | ||
| Q2 25 | — | $52.3M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | $205.2M | $59.7M | ||
| Q3 24 | — | $191.5M | ||
| Q2 24 | — | $111.2M |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.2B | $1.8B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.0B | $1.7B | ||
| Q3 24 | $1.0B | $3.1B | ||
| Q2 24 | $1.0B | $3.6B |
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | $1.8B | $1.7B | ||
| Q2 25 | $1.8B | $1.7B | ||
| Q1 25 | $1.8B | $1.7B | ||
| Q4 24 | $1.8B | $1.7B | ||
| Q3 24 | $1.8B | $1.9B | ||
| Q2 24 | $1.8B | $1.4B |
| Q1 26 | $4.0B | — | ||
| Q4 25 | $3.7B | $5.9B | ||
| Q3 25 | $3.7B | $5.7B | ||
| Q2 25 | $3.7B | $5.7B | ||
| Q1 25 | $3.7B | $5.7B | ||
| Q4 24 | $3.4B | $5.6B | ||
| Q3 24 | $3.4B | $8.0B | ||
| Q2 24 | $3.5B | $7.9B |
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.65× | 1.06× | ||
| Q3 25 | 0.64× | 1.03× | ||
| Q2 25 | 0.66× | 1.10× | ||
| Q1 25 | 0.72× | 1.03× | ||
| Q4 24 | 0.58× | 1.01× | ||
| Q3 24 | 0.58× | 1.62× | ||
| Q2 24 | 0.57× | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $64.3M |
| Free Cash FlowOCF − Capex | $9.1M | $5.2M |
| FCF MarginFCF / Revenue | 0.9% | 0.4% |
| Capex IntensityCapex / Revenue | 1.0% | 4.2% |
| Cash ConversionOCF / Net Profit | — | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $290.6M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $102.3M | $64.3M | ||
| Q3 25 | $83.9M | $175.3M | ||
| Q2 25 | $124.9M | $110.3M | ||
| Q1 25 | $16.8M | $-3.5M | ||
| Q4 24 | $100.2M | $125.4M | ||
| Q3 24 | $135.8M | $181.0M | ||
| Q2 24 | $90.7M | $278.2M |
| Q1 26 | $9.1M | — | ||
| Q4 25 | $93.7M | $5.2M | ||
| Q3 25 | $72.0M | $122.2M | ||
| Q2 25 | $115.8M | $45.6M | ||
| Q1 25 | $6.6M | $-55.8M | ||
| Q4 24 | $88.9M | $62.0M | ||
| Q3 24 | $127.9M | $130.3M | ||
| Q2 24 | $85.4M | $222.6M |
| Q1 26 | 0.9% | — | ||
| Q4 25 | 9.6% | 0.4% | ||
| Q3 25 | 7.1% | 9.0% | ||
| Q2 25 | 11.3% | 3.4% | ||
| Q1 25 | 0.7% | -4.1% | ||
| Q4 24 | 9.0% | 4.7% | ||
| Q3 24 | 12.4% | 10.2% | ||
| Q2 24 | 8.3% | 17.4% |
| Q1 26 | 1.0% | — | ||
| Q4 25 | 0.9% | 4.2% | ||
| Q3 25 | 1.2% | 3.9% | ||
| Q2 25 | 0.9% | 4.8% | ||
| Q1 25 | 1.1% | 3.9% | ||
| Q4 24 | 1.1% | 4.8% | ||
| Q3 24 | 0.8% | 4.0% | ||
| Q2 24 | 0.5% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | 3.19× | ||
| Q3 25 | 2.20× | 6.09× | ||
| Q2 25 | 4.26× | 2.72× | ||
| Q1 25 | 0.80× | -0.06× | ||
| Q4 24 | 2.36× | — | ||
| Q3 24 | 2.86× | 3.25× | ||
| Q2 24 | 1.92× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASGN
Segment breakdown not available.
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
